Accelerate Diagnostics, Inc. announced preliminary unaudited revenue results for the year ended December 31, 2023. Preliminary revenue was approximately $12.1 million for the year, compared to $12.8 million in the prior year. While year-over-year revenues for consumable products increased by approximately 5%, overall annual revenue was down year-over-year due to a challenging capital sales environment in all sales regions.